<?xml version="1.0" encoding="UTF-8"?>
<p id="Par31">Further research and development for new TB drugs is essential. Other areas for research include improving adherence to the drug regimen, which will address the danger of MDR-TB, and better diagnostics. However, the majority of global funding for TB is put into drug production and preventative vaccines, making new cures difficult to come by (Moran et al. 
 <xref ref-type="bibr" rid="CR18">2013</xref>). Internationally, the Global Fund to Fight AIDS, Tuberculosis, and Malaria, provides over 80% of all support to fight TB. This has created a concern about financial dependence.
</p>
